These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 33122123)
21. Indirect Comparison of Lanadelumab and Intravenous C1-INH Using Data from the HELP and CHANGE Studies: Bayesian and Frequentist Analyses. Mendivil J; Malmenäs M; Haeussler K; Hunger M; Jain G; Devercelli G Drugs R D; 2021 Mar; 21(1):113-121. PubMed ID: 33646565 [TBL] [Abstract][Full Text] [Related]
22. An evidence based therapeutic approach to hereditary and acquired angioedema. Bork K Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294 [TBL] [Abstract][Full Text] [Related]
23. Successful management of hereditary angioedema during tonsillectomy: a case report. Hermans C; Vander Vorst S; Lambert C Blood Coagul Fibrinolysis; 2012 Mar; 23(2):155-7. PubMed ID: 22193715 [TBL] [Abstract][Full Text] [Related]
24. A focus on the use of subcutaneous C1-inhibitor for treatment of hereditary angioedema. Villavicencio MF; Craig T Expert Rev Clin Immunol; 2020 May; 16(5):451-455. PubMed ID: 32237900 [TBL] [Abstract][Full Text] [Related]
25. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE). Bork K Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174 [TBL] [Abstract][Full Text] [Related]
27. The diagnosis and treatment of hereditary angioedema patients in Japan: A patient reported outcome survey. Iwamoto K; Yamamoto B; Ohsawa I; Honda D; Horiuchi T; Tanaka A; Fukunaga A; Maehara J; Yamashita K; Akita T; Hide M Allergol Int; 2021 Apr; 70(2):235-243. PubMed ID: 33168485 [TBL] [Abstract][Full Text] [Related]
28. Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: the Italian experience. Cancian M; Curr Opin Allergy Clin Immunol; 2015 Aug; 15(4):383-91. PubMed ID: 26106828 [TBL] [Abstract][Full Text] [Related]
29. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy. Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305 [TBL] [Abstract][Full Text] [Related]
30. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema. Valerieva A; Caccia S; Cicardi M Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471 [TBL] [Abstract][Full Text] [Related]
31. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement. Riedl MA; Li HH; Cicardi M; Harper JR; Relan A Allergy Asthma Proc; 2017 Nov; 38(6):462-466. PubMed ID: 28903805 [TBL] [Abstract][Full Text] [Related]
32. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema. Henry Li H; Riedl M; Kashkin J Clin Rev Allergy Immunol; 2019 Apr; 56(2):207-218. PubMed ID: 29909591 [TBL] [Abstract][Full Text] [Related]
37. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States. Bernstein JA; Moellman JJ Postgrad Med; 2012 May; 124(3):91-100. PubMed ID: 22691903 [TBL] [Abstract][Full Text] [Related]
38. Outcomes of long term treatments of type I hereditary angioedema in a Turkish family. Akoglu G; Kesim B; Yildiz G; Metin A An Bras Dermatol; 2017; 92(5):655-660. PubMed ID: 29166502 [TBL] [Abstract][Full Text] [Related]
39. Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedema. Bernstein JA; Schwartz L; Yang W; Baker J; Anderson J; Farkas H; Aygören-Pürsün E; Bygum A; Jacobs I; Feuersenger H; Pragst I; Riedl MA Ann Allergy Asthma Immunol; 2020 Sep; 125(3):334-340.e1. PubMed ID: 32445670 [TBL] [Abstract][Full Text] [Related]
40. Effect of lanadelumab on attack frequency and QoL in Japanese patients with hereditary angioedema: Report of five cases. Hioki C; Oda Y; Moriwaki S; Fukunaga A J Dermatol; 2024 Jun; 51(6):873-877. PubMed ID: 38268496 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]